RN7SK pseudogene 200 (RN7SKP200)

RN7SK pseudogene 200 (RN7SKP200) is cataloged as a pseudogene variant of the functional non-coding RNA gene RN7SK, which encodes a ubiquitous small nuclear RNA involved in the regulation of transcription elongation[3][4][5]. Pseudogenes are typically non-functional genomic DNA sequences resembling functional genes but generally do not produce functional products. There are no known biological functions, disease associations, or pharmacological interactions for RN7SKP200. If a functional context or biological activities are required for drug discovery or therapeutic targeting, the focus should be on the RN7SK small nuclear RNA, not the pseudogene. Explanation: RN7SKP200 appears to be a computational annotation for a pseudogene. Pseudogenes, by definition, are gene sequences that resemble known genes but are non-functional due to mutations or lack of regulatory elements. They are not considered therapeutic targets[3]. The functional RN7SK gene encodes a 7SK small nuclear RNA—a well-characterized long non-coding RNA that regulates the activity of RNA polymerase II by sequestering the positive transcription elongation factor b (P-TEFb), impacting cellular processes like cell proliferation, differentiation, and senescence[1][2][3][4][5]. However, this functionality does not extend to pseudogenes. No therapeutic agents, small molecules, or biomarker roles are assigned to RN7SKP200 (the pseudogene) in the scientific or medical literature[3][4][5]. If your intent was to retrieve data for the functional target, use “RN7SK small nuclear RNA” (abbreviation: RN7SK), not the pseudogene designation. Summary: RN7SKP200 is a pseudogene, not a functional molecular target, and thus does not meet criteria for a receptor, enzyme, transporter, or similar therapeutic entity. For biological, therapeutic, or target annotation, refer instead to the functional RN7SK small nuclear RNA.

Other names

RN7SKP200RN7SK pseudogene 200